NASDAQ:TVTX | Operating Income | Travere Therapeutics, Inc.

Complete source-backed operating income history.

Available history
2012-03-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30$3.95M
2026-03-31-$36.92M
2025-12-31-$32.43M
2025-09-30$24.93M
2025-06-30-$12.65M
2025-03-31-$42.67M
2024-12-31-$60.74M
2024-09-30-$56.15M
2024-06-30-$67.7M
2024-03-31-$139.24M
2023-12-31-$94.23M
2023-09-30-$92.59M
2023-06-30-$103.95M
2023-03-31-$97.37M
2022-12-31-$86.7M
2022-09-30-$82.6M
2022-06-30-$65.45M
2022-03-31-$66.13M
2021-12-31-$84.85M
2021-09-30-$31.71M
2021-06-30-$35.32M
2021-03-31-$47.55M
2020-12-31-$118.55M
2020-09-30-$19.44M
2020-06-30-$23.11M
2020-03-31-$15.07M
2019-12-31-$28.17M
2019-09-30-$34.44M
2019-06-30-$36.53M
2019-03-31-$38.23M
2018-12-31-$4.99M
2018-09-30-$35.58M
2018-06-30-$21.56M
2018-03-31-$17.91M
2017-12-31-$15.18M
2017-09-30-$10.61M
2017-06-30-$13.6M
2017-03-31-$14.41M
2016-12-31-$18.22M
2016-09-30-$20.37M
2016-06-30-$11.38M
2016-03-31-$8.24M
2015-12-31-$15.2M
2015-09-30-$20.5M
2015-06-30-$6.94M
2015-03-31-$8.1M
2014-12-31-$18.7M
2014-09-30-$21.87M
2014-06-30-$17.18M
2014-03-31-$22.06M
2013-12-31-$12.27M
2013-09-30-$5.15M
2013-06-30-$5.1M
2013-03-31-$1.89M
2012-12-31-$13.5M
2012-09-30-$8.46M
2012-06-30-$4.74M
2012-03-31-$3.56M

Annual Operating Income

DateOperating Income
2025-12-31-$62.82M
2024-12-31-$323.83M
2023-12-31-$388.14M
2022-12-31-$319.81M
2021-12-31-$199.43M
2020-12-31-$176.16M
2019-12-31-$137.36M
2018-12-31-$80.04M
2017-12-31-$53.79M
2016-12-31-$58.21M
2015-12-31-$50.75M
2014-12-31-$79.81M
2013-12-31-$24.77M
2012-12-31-$30.26M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.